Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2
about
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanomaAdoptive cell transfer: a clinical path to effective cancer immunotherapyCancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytesSorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?Adoptive cell transfer as personalized immunotherapy for human cancer.Targeting CD8+ T-cell tolerance for cancer immunotherapy.Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccinationThe clinical effects of dendritic cell vaccines combined with cytokine-induced killer cells intraperitoneal injected on patients with malignant ascitesThe immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein.Immunotherapy with sensitized lymphocytes.Tumor-infiltrating lymphocytes in melanoma.The past, present, and future of adoptive T cell therapy.Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus.Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejectionMolecular cloning of human interleukin 2 cDNA and its expression in E. coli.Vaccine-based approaches to squamous cell carcinoma of the head and neck.How to detour Treg cells in T cell-based antitumor immune therapy.Progress and challenges in the vaccine-based treatment of head and neck cancers.Enhancing adoptive immunotherapy of cancer.Tumor-infiltrating lymphocytes for the treatment of metastatic cancer.Effects of scrocaffeside A from Picrorhiza Scrophulariiflora on immunocyte function in vitro.Natural killer cells and cancer.Enhancement of anti-tumor activity of natural killer cells by BALL-1, a B cell lymphoma line.Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.Suppression of the generation of lymphokine-activated killer (LAK) cells by serum-free supernatants of in vitro maintained tumour cell lines.Immunoregulation of murine plasmacytoma. I. Generation of anomalous killer cells in vitro by cocultivation with MOPC 104E.Early development of CD8-negative and CD8-positive MHC-unrestricted cytotoxic cells induced by alloantigen inoculation in mice.Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity.Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.Lymphokine-activated killer cells in mouse bone marrow chimaeras. The relationship to natural killer cells and to alloreactive cytotoxic T cells.The roles of CD8+ and CD4+ cells in tumor rejection.Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies
P2860
Q24548019-5C3ABF52-B942-402D-8F8F-785CA2C7AFB0Q24644774-D9B52FED-A4DF-45D0-910A-9C7C3198A56EQ24676216-B84E941F-5CD3-41CD-B68F-7B9A381F3F8BQ27002575-AA5542B2-E253-4618-9406-0A9E90C47651Q34043643-6A4CC495-E7D9-48DA-B298-D9E81FA568D7Q34432692-1BB8D0BF-A094-4C5D-B260-B9850D9BD8F1Q34759603-D751C8E9-6876-4CD4-926D-4619A258A90CQ34769958-01431FB2-FC4E-4FC3-AA5C-9F9B02D48EE8Q35049933-2A452FDE-7BD6-45AC-8FB1-1B83C3B344E0Q35367163-FC4D95FB-AC72-4BEB-9C47-3CBF8428E2F2Q36292200-91D097C0-E662-4DDB-8E00-711F25316EABQ36306644-77219F00-907A-41BF-A05C-31246FA7FF68Q36348066-3B05F16D-F4B0-4C48-9381-A2A8CB712B1CQ36348452-04FFB0B0-840B-4544-88DB-C0497885D321Q36349864-DC5B5BBD-A02A-4B6B-8263-97CDB3027C9CQ36597657-93AF89B6-415F-40D6-9E5A-F9465149E10BQ36714541-CC33590F-B30C-47E1-AA67-2B547256EBCCQ37169964-62B80A3D-2468-41BA-8156-F894B28B175FQ37224926-8E177106-4EAC-4833-AEE1-009FE4409B5FQ37687429-E5B67277-08EB-4BF8-9865-77CB90EE4B42Q38636573-11478C70-9EA6-4511-9DD5-94370FFAAF8EQ39953906-356EE4F7-E5CD-4FAB-9D83-E6467B6B19E0Q40945896-BBA1B9A9-439F-416A-853E-53F0BCC58D7DQ41036448-6FA5D3C2-0FEC-4846-8A7F-D0FAAC925740Q41547207-80F52C15-5EC0-4D3D-8B65-F3B6079BEC5DQ43051084-DC39806C-6F57-45B3-A03D-1E9C1F14EB07Q43561202-E4B3E87D-63FA-437C-8F60-2C51440622BBQ44636635-32D6003E-FAB9-4850-9278-487680D41622Q47565901-E558D60D-729A-41EC-B4A6-9FEEFF25CF2AQ51763013-EF8562A7-49F0-4FD5-8491-3599ED5BB335Q54442397-7BF6358D-0343-4D17-8940-DD79B05A1050Q55283530-45FED1E4-AAC6-43FB-9710-44A203770772Q57172250-FD36F1CD-28EB-4E92-8C76-F471EAD28EF4
P2860
Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Regression of a disseminated s ...... ells expanded in interleukin 2
@ast
Regression of a disseminated s ...... ells expanded in interleukin 2
@en
type
label
Regression of a disseminated s ...... ells expanded in interleukin 2
@ast
Regression of a disseminated s ...... ells expanded in interleukin 2
@en
prefLabel
Regression of a disseminated s ...... ells expanded in interleukin 2
@ast
Regression of a disseminated s ...... ells expanded in interleukin 2
@en
P2093
P2860
P356
P1476
Regression of a disseminated s ...... ells expanded in interleukin 2
@en
P2093
Eberlein TJ
Rosenberg SA
Rosenstein M
P2860
P304
P356
10.1084/JEM.156.2.385
P407
P577
1982-08-01T00:00:00Z